home *** CD-ROM | disk | FTP | other *** search
- <text id=90TT1378>
- <title>
- May 28, 1990: Just What The Patient Ordered
- </title>
- <history>
- TIME--The Weekly Newsmagazine--1990
- May 28, 1990 Emergency!
- </history>
- <article>
- <source>Time Magazine</source>
- <hdr>
- HEALTH, Page 42
- Just What the Patient Ordered
- </hdr>
- <body>
- <p>Prescription drug ads make doctors edgy and consumers curious
- </p>
- <p> One morning this month, Dr. Michael Buenaflor, a family
- practitioner in Northampton, Pa., took a call from a patient
- who wanted a prescription. And not just any prescription. The
- caller insisted on Nicorette, a drug intended to help people
- stop smoking. How did he find out about it? From an
- advertisement. When Buenaflor suggested that the drug might not
- be appropriate for prolonged use, since the patient had a heart
- condition and an ulcer, the man hung up and took his "business"
- elsewhere. Concludes Buenaflor: "The pressure to use these
- drugs is incredible."
- </p>
- <p> At issue is a new trend in the drug industry: a growing
- number of prescription medications, from allergy tablets to
- birth-control pills, are being promoted directly to consumers
- in newspaper and magazine ads and even a few TV commercials.
- Drug companies and some physicians say the ads help educate
- patients and give consumers a chance to become more involved
- in choosing the medications they want. But many doctors deplore
- the marketing tactic. Argues Dr. Nancy Dickey of the American
- Medical Association: "Splashy ads with limited information are
- no substitute for four years of medical school and many more of
- professional training."
- </p>
- <p> Until recently, pharmaceutical companies generally contented
- themselves with a softer sell that refrained from mentioning
- products by name. Ads simply urged those with ulcers or
- thinning hair, for example, to see their doctor. But increasing
- competition has spurred some companies to be more aggressive.
- Last month Marion Merrell Dow launched a major campaign for the
- allergy medication Seldane, pitching the drug by name for the
- first time. Other prescription drugs that have appeared in
- name-brand ads in the past year include Rogaine, Upjohn's
- antibaldness medication, and Procardia XL, a heart drug from
- Pfizer.
- </p>
- <p> The ads are subject to strict Government regulations. If
- they tout a drug by name for a particular illness, they must
- include a thicket of fine print listing "contraindications" and
- "adverse reactions." Such verbosity is impractical on TV, but
- a few companies have sidestepped the problem by keeping their
- messages simple enough to be within the rules. Marion Merrell
- Dow, for example, has run TV ads for Nicorette that avoid
- mentioning what the drug is for.
- </p>
- <p> The danger from prescription-drug ads is that they can
- mislead patients into believing they know better than their
- physician which medicine is best. Says Dr. Israeli Jaffe, a
- professor at Columbia University: "There's no question that
- certain physicians are being influenced to issue prescriptions
- that they would not otherwise write." Many doctors also feel
- that the cost of nationwide advertising could needlessly
- inflate the price of treatment.
- </p>
- <p> But drug companies and even some doctors argue that the ads
- can provide information and encourage otherwise reluctant
- patients to seek help. Advertising could also help dispel some
- of the mystery surrounding prescription medication and enable
- people to take a more active role in their own treatment. Dr.
- Warren Pearse of the American College of Obstetricians and
- Gynecologists feels that more ads for oral contraceptives would
- provide women with a better picture of birth-control
- alternatives. "The days of keeping patients in the dark have
- passed," he says.
- </p>
- <p> Congress has noticed the ads, and Michigan Democrat John
- Dingell is among those considering new restrictions. In the
- meantime, many doctors have taken a fresh interest in the
- popular media. Says Buenaflor: "We need to keep an eye on the
- competition."
- </p>
- <p>By Andrew Purvis.
- </p>
-
- </body>
- </article>
- </text>
-
-